Redsenol Ginseng and ginsenosides
Rare ginsenosides, the metabolite of prototype ginsenosides, are active components in the ginseng which exhibit powerful anticancer activities, including inducing apoptosis of cancerous cells, inhibiting angiogenesis in malignant lesions, alleviating toxicity induced by chemotherapy...
Scientists from Department of Surgery, University of British Columbia, Vancouver, British Columbia in Canada have discovered that 20S-Protopanaxadiol(aPPD) inhibits P-glycoprotein in multidrug-resistant cancer cells. The growing resistance to anticancer drugs has become a global concern, threatening...
Chemotherapy is currently the main method of treating cancer used in clinical practices. Despite the brilliant performance in combating cancer cells, the treatment still accompanies side effects. Combination therapy, a new treatment that administrates a conventional...
Ginsenosides are natural compounds extracted from Araliaceae plants like Panax ginseng. Since ginsenosides were found to exhibit anticancer property in the 1960s, scientists have been working on the study of rare ginsenosides. With in-depth research...
Recently, a research team led by Chinese researchers from State Key Laboratory of Natural Medicines, China Pharmaceutical University published a study in the journal Cell Death & Disease, Nature, revealing that ginsenoside Rg5 increases cardiomyocyte resistance to...
Ginsenoside Rh4 induces apoptosis and autophagic cell death through activation of the ROS/JNK/p53 pathway in colorectal cancer cells, according to the study published in the journal Biochemical Pharmacology. Ginsenosides are natural compounds extracted from Araliaceae...
Calcitriol and 20(S)-protopanaxadiol(aPPD) synergistically inhibit growth and induce apoptosis in human prostate cancer cells, according to the study published in the Journal of Steroid Biochemistry and Molecular Biology. Prostate cancer is one of the...
Recently, researchers from College of Life Sciences, Kyung Hee University in the Republic of Korea published a study in the Iranian Journal of Biotechnology, finding that ginsenoside Rg5: Rk1 exerts an anti-obesity effect on 3T3-L1...
Recently, a research team led by Clemens A. Schmitt, a professor in the Department of Hematology, Oncology, and Tumor Immunology at Charité-University Medical Center in Berlin, Germany, published a breakthrough study in the journal...
Ginsenoside Rk3 exhibits anticancer effects on non-small cell lung cancer (NSCLC) cells and can be a new promising therapeutic agent for lung cancer treatment, according to the paper titled “Anticancer effects of ginsenoside Rk3 on...
